side effects of semaglutide and tirzepatide caused roughly half as many patients to stop treatment because gastrointestinal as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Health Tip of the Week,

PLoS One 8, e57236

Sometimes, it can be hard to tell if semaglutide is the main reason for the cramps or if something else is going on

While more research is needed to fully understand the mechanisms at play, these findings suggest a promising link between glutathione and blood pressure management

A therapy area market with $131bn of global value would immediately become the fourth member of the mega-therapy areas which are substantially more valuable, and drive more of the value growth, of the global prescription medicine market

Different peptides may have different compatibility, stability and storage requirements

The mitigation is clear and evidence-based: personalized protein targets (minimum 1.21.6g per kg body weight daily) and resistance exercise throughout treatment